IE00BF0H7608
IE00BF0H7608
L&G Pharma Breakthrough UCITS ETF
Loading chart...
About this ETF
The L&G Pharma Breakthrough UCITS ETF seeks to track the Solactive Pharma Breakthrough Value index. The Solactive Pharma Breakthrough Value index tracks companies involved in the development and manufacturing of so-called "orphan drugs". Orphan drugs are drugs that target very rare diseases.
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
16.94
Weighted Fwd P/E
20.5
💰 Revenue Estimates
Current Year CY
+23.64% ⌀ 14 Analysts Coverage
Next Year NY
+13.76% ⌀ 14 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
-40.55% ⌀ 11 Analysts Coverage
Next Year NY
+237.5% ⌀ 11 Analysts Coverage
Related ETFs
Xtrackers World Small Cap Green Tech Innovators UCITS ETF 1C
39.54 EUR
TER 0.45% 1Y +20.8%
Xtrackers World Green Tech Innovators UCITS ETF 1C
35.23 EUR
TER 0.35% 1Y +15.2%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
43.65 USD
TER 0.3% 1Y +62.3%
ETF Profile
Provider
Fund Type
ETF Type
Passive Inception Date
01/23/2018 (8 yrs)
Index Group
Solactive Pharma Breakthrough Value Region
World Country
-
Sector
Health Care Strategy
-
Theme
Innovation Distribution Policy
Accumulating Replication
Full replication Sustainable
No